Feasibility and suitability of a graded exercise test in patients with aggressive hemato-oncological disease

Simple item page
dc.contributor.authorGroßek, Anja
dc.contributor.authorElter, Thomas
dc.contributor.authorOberste, Max
dc.contributor.authorWolf, Florian
dc.contributor.authorJoisten, Niklas
dc.contributor.authorHartig, Philipp
dc.contributor.authorWalzik, David
dc.contributor.authorRosenberger, Friederike
dc.contributor.authorKiesl, David
dc.contributor.authorWahl, Patrick
dc.contributor.authorBloch, Wilhelm
dc.contributor.authorZimmer, Philipp
dc.date.accessioned2021-03-30T06:51:25Z
dc.date.available2021-03-30T06:51:25Z
dc.date.issued2021-02-05
dc.description.abstractPurpose Physical activity promises to reduce disease-related symptoms and therapy-related side effects in patients suffering from aggressive lymphoma (L) or acute leukemia (AL). For an efficient training program, determination of patients’ physical capacity with a purposive exercise test is crucial. Here, we evaluated the feasibility and suitability of a graded exercise test (GXT) frequently applied in patients suffering from solid tumors by assessing whether patients achieved criteria for maximal exercise testing according to the American College of Sports Medicine (ACSM). Methods The GXT was performed by 51 patients with an aggressive L or AL prior to the start or in the earliest possible phase of high-dose chemotherapy, following a recommended protocol for cancer patients, starting at 20 Watts (W), with an increase of 10 W/min until volitional exhaustion. Subsequently, we investigated whether the following ACSM criteria were fulfilled: (1) failure of heart rate to increase despite increasing workload, (2) post-exercise capillary lactate concentration ≥ 8.0 mmol L−1, (3) rating of perceived exertion at exercise cessation > 17 on the 6–20 Borg Scale. Results Out of 51 patients, two, six, and 35 participants met the first, second, and third criterion, respectively. No relevant relationships between the completion of the criteria and patients’ characteristics (e.g., gender, age) were found. Conclusion Although results of this study suggest a general feasibility of the applied GXT, the ACSM criteria were not met by the majority of the participants. Therefore, this study raises doubts about the suitability of the GXT protocol and the ACSM criteria for this group of patients.en
dc.identifier.urihttp://hdl.handle.net/2003/40118
dc.identifier.urihttp://dx.doi.org/10.17877/DE290R-21995
dc.language.isoende
dc.relation.ispartofseriesSupport Care Cancer;
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectAcute leukemiaen
dc.subjectLymphomaen
dc.subjectExercise testen
dc.subjectACSM criteriaen
dc.subject.ddc796
dc.subject.rswkAkute Leukämiede
dc.subject.rswkLymphomde
dc.subject.rswkBelastungstestde
dc.titleFeasibility and suitability of a graded exercise test in patients with aggressive hemato-oncological diseaseen
dc.typeTextde
dc.type.publicationtypearticlede
dcterms.accessRightsopen access
eldorado.secondarypublicationtruede
eldorado.secondarypublication.primarycitationGroßek, A., Elter, T., Oberste, M. et al. Feasibility and suitability of a graded exercise test in patients with aggressive hemato-oncological disease. Support Care Cancer (2021).de
eldorado.secondarypublication.primaryidentifierhttps://doi.org/10.1007/s00520-021-06035-wde

Files

Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Großek2021_Article_FeasibilityAndSuitabilityOfAGr.pdf
Size:
280.43 KB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
4.85 KB
Format:
Item-specific license agreed upon to submission
Description:
Download

Collections

Institut für Sport und Sportwissenschaft